Published in J Clin Invest on May 01, 1981
Tubo-ovarian abscess: pathogenesis and management. J Natl Med Assoc (1986) 0.78
Proteolysis of complement factors iC3b and C5 by the serine protease prostate-specific antigen in prostatic fluid and seminal plasma. J Immunol (2013) 0.76
Gonorrhea - an evolving disease of the new millennium. Microb Cell (2016) 0.75
Culture and identification of Borrelia spirochetes in human vaginal and seminal secretions. F1000Res (2014) 0.75
Equine arteritis virus elicits a mucosal antibody response in the reproductive tract of persistently infected stallions. Clin Vaccine Immunol (2017) 0.75
Protein measurement with the Folin phenol reagent. J Biol Chem (1951) 1743.91
NEISSERIA GONORRHOEAE. I. VIRULENCE GENETICALLY LINKED TO CLONAL VARIATION. J Bacteriol (1963) 45.03
Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphrenylglycoluril. Biochem Biophys Res Commun (1978) 32.33
Surface-specific iodination of membrane proteins of viruses and eucaryotic cells using 1,3,4,6-tetrachloro-3alpha,6alpha-diphenylglycoluril. Biochemistry (1978) 9.04
Role of myeloperoxidase-mediated antimicrobial systems in intact leukocytes. J Reticuloendothel Soc (1972) 4.60
Quantitative leukocyte iodination. N Engl J Med (1971) 3.46
Human deficiency of the eighth component of complement. The requirement of C8 for serum Neisseria gonorrhoeae bactericidal activity. J Clin Invest (1976) 2.45
In vitro evaluation of opsonic and cellular granulocyte function by luminol-dependent chemiluminescence: utility in patients with severe neutropenia and cellular deficiency states. Infect Immun (1978) 2.33
Bactericidal activity of meningococcal antisera. Blocking by IgA of lytic antibody in human convalescent sera. J Immunol (1975) 2.15
Bactericidal and opsonic activity against Neisseria gonorrhoeae in sera from patients with disseminated gonococcal infection. J Infect Dis (1976) 1.91
Inhibition of adherence of Neisseria gonorrhoeae by human genital secretions. J Clin Invest (1977) 1.61
Effect of local infection and oral contraception on immunoglobulin levels in cervical mucus. Infect Immun (1975) 1.59
Correction of leukocyte function in Chediak-Higashi syndrome by ascorbate. N Engl J Med (1976) 1.52
In vitro synthesis of immunoglobulins, secretory component and complement in normal and pathological skin and the adjacent mucous membranes. Clin Exp Immunol (1973) 1.50
Familial deficiency of the seventh component of complement associated with recurrent bacteremic infections due to Neisseria. J Infect Dis (1978) 1.39
Phospholipid composition and phospholipase A activity of Neisseria gonorrhoeae. J Bacteriol (1976) 1.36
The presence of complement in human cervical mucus and its possible relevance to infertility in women with complement-dependent sperm-immobilizing antibodies. Fertil Steril (1979) 1.32
Immunosuppressive activity of human seminal plasma. I. Inhibition of in vitro lymphocyte activation. J Immunol (1977) 1.26
The effects of ascorbic acid on bactericidal mechanisms of neutrophils. J Infect Dis (1971) 1.19
Bactericidal antibody in genital infection due to Neisseria gonorrhoeae. J Infect Dis (1977) 1.14
In vitro studies in reproductive immunology. 1. Suppression of cell-mediated immune response by human spermatozoa and fractions isolated from human seminal plasma. Clin Immunol Immunopathol (1978) 1.13
Studies on the relationships between serum bactericidal activity and uncomplicated genital infections due to Neisseria gonorrhoeae. J Infect Dis (1978) 1.12
Human seminal plasma inhibition of complement. J Lab Clin Med (1980) 1.11
Suppressive effect of seminal plasma on lymphocyte activation. Nature (1975) 1.06
Inhibition of in vitro immune responses by a fraction from seminal plasma. Scand J Immunol (1976) 1.03
X-ray effects on hemolysin formation in rabbits with the spleen shielded or irradiated. J Infect Dis (1957) 0.93
Biochemistry of cervical mucus. Fertil Steril (1970) 0.87
In vitro effects of ascorbate on white cell metabolism and the chemiluminescence response. J Reticuloendothel Soc (1980) 0.80
Changes in endometrial ground substance. J Reprod Med (1970) 0.77
CD8+ lymphocytes can control HIV infection in vitro by suppressing virus replication. Science (1986) 9.17
Differential ability of human immunodeficiency virus isolates to productively infect human cells. J Immunol (1987) 3.19
Human immunodeficiency virus can productively infect cultured human glial cells. Proc Natl Acad Sci U S A (1987) 3.14
Antibodies to a scrapie prion protein. Nature (1984) 3.09
Wiskott-Aldrich syndrome, a genetically determined cellular immunologic deficiency: clinical and laboratory responses to therapy with transfer factor. Proc Natl Acad Sci U S A (1970) 2.89
DNA amplification and reverse dot blot hybridization for detection and identification of mycobacteria to the species level in the clinical laboratory. J Clin Microbiol (1992) 2.71
Eikenella corrodens, a recently recognized pathogen: infections in medical-surgical patients and in association with methylphenidate abuse. Medicine (Baltimore) (1974) 2.61
Neisseria meningitidis and Neisseria gonorrhoeae bacteremia associated with C6, C7, or C8 deficiency. Ann Intern Med (1979) 2.51
Human deficiency of the eighth component of complement. The requirement of C8 for serum Neisseria gonorrhoeae bactericidal activity. J Clin Invest (1976) 2.45
Comparison of PCR detection of mecA with standard susceptibility testing methods to determine methicillin resistance in coagulase-negative staphylococci. J Clin Microbiol (1996) 2.37
Factor 8 detection by hemagglutination inhibition: hemophilia A and von Willebrand's disease. Science (1971) 2.27
Modification by sialic acid of Neisseria gonorrhoeae lipooligosaccharide epitope expression in human urethral exudates: an immunoelectron microscopic analysis. J Infect Dis (1990) 2.22
In vitro anti-human immunodeficiency virus activities of tumor necrosis factor-alpha and interferon-gamma. J Immunol (1988) 2.21
Effects of storage temperature and pH on the stability of eleven beta-lactam antibiotics in MIC trays. J Clin Microbiol (1985) 2.21
Bacillary angiomatosis and bacillary splenitis in immunocompetent adults. Ann Intern Med (1993) 2.14
Comparison of virulence markers of peritoneal and fallopian tube isolates with endocervical Neisseria gonorrhoeae isolates from women with acute salpingitis. Infect Immun (1980) 2.11
Bactericidal and opsonic activity against Neisseria gonorrhoeae in sera from patients with disseminated gonococcal infection. J Infect Dis (1976) 1.91
Semi-automated entry of clinical temporal-abstraction knowledge. J Am Med Inform Assoc (1999) 1.81
Human cell-mediated immune responses to chlamydial antigens. Infect Immun (1979) 1.76
Microbiology and pathogenesis of acute salpingitis as determined by laparoscopy: what is the appropriate site to sample? Am J Obstet Gynecol (1980) 1.71
Repeated gonorrhea: an analysis of importance and risk factors. J Infect Dis (1978) 1.70
Studies of hepatic synthesis in vivo of plasma proteins, including orosomucoid, transferrin, alpha 1-antitrypsin, C8, and factor B. Clin Immunol Immunopathol (1980) 1.69
Flow cytometric analysis of lymphocyte phenotypes in AIDS using monoclonal antibodies and simultaneous dual immunofluorescence. Clin Immunol Immunopathol (1986) 1.68
Long-term cultivation of T-cell subsets from patients with acquired immune deficiency syndrome. Clin Immunol Immunopathol (1985) 1.65
Characterization of antimicrobial resistance in Streptococcus pyogenes isolates from the San Francisco Bay area of northern California. J Clin Microbiol (1999) 1.59
An AIDS-related cytotoxic autoantibody reacts with a specific antigen on stimulated CD4+ T cells. Nature (1987) 1.57
Cytotoxic T lymphocyte responses to E6 and E7 proteins of human papillomavirus type 16: relationship to cervical intraepithelial neoplasia. J Infect Dis (1997) 1.57
Histoplasmosis in immunosuppressed patients. Am J Med (1978) 1.54
Evaluation of broth media for routine culture of cerebrospinal and joint fluid specimens. Am J Clin Pathol (1988) 1.54
Exogenous immunoglobulin and the macrophage origin of Reed-Sternberg cells in Hodgkin's disease. N Engl J Med (1978) 1.51
Persistence of human papillomavirus type 16 infection is associated with lack of cytotoxic T lymphocyte response to the E6 antigens. J Infect Dis (2000) 1.50
Relation of protein I and colony opacity to serum killing of Neisseria gonorrhoeae. J Infect Dis (1982) 1.50
The Wiskott-Aldrich syndrome. Results of transfer factor therapy. J Clin Invest (1972) 1.50
Diphtheria in the United States, 1959-1970. J Infect Dis (1974) 1.47
Genetic control of scrapie and Creutzfeldt-Jakob disease in mice. J Immunol (1983) 1.41
Antibody-antigen specificity in the immune response to infection with Neisseria gonorrhoeae. J Infect Dis (1985) 1.39
Phospholipid composition and phospholipase A activity of Neisseria gonorrhoeae. J Bacteriol (1976) 1.36
CD8+ T lymphocyte control of HIV replication in cultured CD4+ cells varies among infected individuals. Cell Immunol (1989) 1.36
Serum bactericidal action and activation of the classic and alternate complement pathways by Neisseria gonorrhoeae. J Lab Clin Med (1978) 1.34
Evaluation of the autoSCAN-W/A rapid system for identification and susceptibility testing of gram-negative fermentative bacilli. J Clin Microbiol (1992) 1.32
Hypothesis: AIDS is an autoimmune disease directed at the immune system and triggered by a lymphotropic retrovirus. Clin Immunol Immunopathol (1986) 1.31
Early diagnosis of bacteremia by buffy-coat examinations. Arch Intern Med (1973) 1.29
Dissociation of responses to phytohaemagglutinin and adult allogeneic lymphocytes in human foetal lymphoid tissues. Nat New Biol (1973) 1.28
Differential immune system changes with acute and persistent stress for optimists vs pessimists. Brain Behav Immun (1999) 1.28
Immunosuppressive activity of human seminal plasma. I. Inhibition of in vitro lymphocyte activation. J Immunol (1977) 1.26
Inhibition of Neisseria gonorrhoeae attachment to HeLa cells with monoclonal antibody directed against a protein II. Infect Immun (1983) 1.26
In vitro model of Haemophilus ducreyi adherence to and entry into eukaryotic cells of genital origin. J Infect Dis (1993) 1.25
Lymphocyte proliferative responses to human immunodeficiency virus antigens in vitro. J Clin Invest (1989) 1.25
Antimicrobial therapy. Cost-benefit considerations. Drugs (1989) 1.22
Serologic therapy of tetanus in the United States, 1965-1971. JAMA (1976) 1.20
Complement consumption gonococcal peptidoglycan. Infect Immun (1982) 1.19
Human chorionic gonadotropin: effects of crude and purified preparations on lymphocyte responses to phytohemagglutinin and allogenenic stimulation. J Immunol (1975) 1.19
Mechanism of immunosuppression of progesterone on maternal lymphocyte activation during pregnancy. J Immunol (1979) 1.18
Disorders of neutrophil function. Defects in the early stages of the phagocytic process. Clin Exp Immunol (1973) 1.18
Th1 cytokine patterns in cervical human papillomavirus infection. Clin Diagn Lab Immunol (1999) 1.18
The effects of human immunodeficiency virus recombinant envelope glycoprotein on immune cell functions in vitro. Cell Immunol (1987) 1.17
Steroids as immunosuppressants in pregnancy. Immunol Rev (1983) 1.14
Comparison of six methods for the detection of antibody to cytomegalovirus. J Clin Microbiol (1985) 1.14
Clinical correlation of strain differentiation of Neisseria gonorrhoeae. J Infect Dis (1976) 1.13
Studies on the relationships between serum bactericidal activity and uncomplicated genital infections due to Neisseria gonorrhoeae. J Infect Dis (1978) 1.12
Immune responses to chlamydial antigens in humans. Med Microbiol Immunol (1982) 1.11
The Austin, Texas, diphtheria outbreak. Clinical and epidemiological aspects. JAMA (1970) 1.11
Antibodies against IgA1 protease are stimulated both by clinical disease and asymptomatic carriage of serogroup A Neisseria meningitidis. J Infect Dis (1992) 1.11
Cellular immune aspects of the human fetal-maternal relationship. I. In vitro response of cord blood lymphocytes to phytohemagglutinin. Cell Immunol (1972) 1.11
Human seminal plasma inhibition of complement. J Lab Clin Med (1980) 1.11
Ontogeny of cellular immunity in the human fetus: development of responses to phytohemagglutinin and to allogeneic cells. Cell Immunol (1974) 1.10
Immunologic and endocrine interrelationships in pregnancy. Biol Reprod (1982) 1.08
Clinical use of the new beta-lactam antimicrobial drugs. Practical considerations for physicians, microbiology laboratories, pharmacists, and formulary committees. Ann Intern Med (1983) 1.08
Letter: Origin of Hodgkin's cell. Lancet (1974) 1.07
Two types of dysfunctional eighth component of complement (C8) molecules in C8 deficiency in man. Reconstitution of normal C8 from the mixture of two abnormal C8 molecules. J Clin Invest (1983) 1.06
Suppression of polyclonal B cell activation in scrapie-infected C3H/HeJ mice. J Immunol (1978) 1.06
Suppressive effect of seminal plasma on lymphocyte activation. Nature (1975) 1.06
Effects of psychosocial treatment in prolonging cancer survival may be mediated by neuroimmune pathways. Ann N Y Acad Sci (1998) 1.05
Abnormal kinetics of degranulation in chronic granulomatous disease. N Engl J Med (1974) 1.04
Comparison of a semiautomated fluorescent immunoassay system and indirect immunofluorescence for detection of antinuclear antibodies in human serum. J Clin Microbiol (1979) 1.04
Serum IgE concentrations in hypogammaglobulinaemia and selective IgA deficiency. Studies on patients and family members. Clin Exp Immunol (1972) 1.04
Ontogeny of immunity in humans. Clin Immunol Immunopathol (1975) 1.04
Development of cellular immunity in the human fetus: dichotomy of proliferative and cytotoxic responses of lymphoid cells to phytohemagglutinin. Proc Natl Acad Sci U S A (1972) 1.04
Neisseria gonorrhoeae coordinately uses Pili and Opa to activate HEC-1-B cell microvilli, which causes engulfment of the gonococci. Infect Immun (1999) 1.04
Cellular immune aspects of the human fetal maternal relationship. II. In vitro response of gravida lymphocytes to phytohemagglutinin. Cell Immunol (1973) 1.03
Genetic control of the eighth component of complement. J Clin Invest (1979) 1.03
The tularemia skin test. 325 skin tests in 210 persons: serologic correlation and review of the literature. Ann Intern Med (1971) 1.03
The limitation of individual cells to the production of a single specificity of antibody in response to a coupled hapten-antigen complex. Immunochemistry (1969) 1.02
Effect of storage temperature and pH on the stability of antimicrobial agents in MIC trays. J Clin Microbiol (1986) 1.01
Antigen-reactive T cells can be activated buy autologous macrophages in the absence of added antigen. J Exp Med (1981) 1.01
An unusual Neisseria isolated from conjunctival cultures in rural Egypt. J Infect Dis (1986) 1.01
Expression of gonococcal protein II in Escherichia coli by translational fusion. Mol Microbiol (1989) 1.00
Evaluation of the indirect immunofluorescence assay as a confirmatory test for detecting antibodies to the human immunodeficiency virus. Diagn Immunol (1986) 0.99